• 1. An atomically efficient, highly stable and redox active Ce0.5Tb0.5Ox (3% mol.)/MgO catalyst for total oxidation of methane?
  Juan J. Sánchez,Miguel López-Haro,Juan C. Hernández-Garrido,Ginesa Blanco,Miguel A. Cauqui,José M. Rodríguez-Izquierdo,José A. Pérez-Omil,José J. Calvino,María P. Yeste J. Mater. Chem. A, 2019,7, 8993-9003
• 2. An approach to biodegradable star polymeric architectures using disulfide coupling?
  Jingquan Liu,Huiyun Liu,Zhongfan Jia,Volga Bulmus,Thomas P. Davis Chem. Commun., 2008, 6582-6584
• 3. An air-stable organometallic polymer containing titanafluorene moieties obtained by the Sonogashira–Hagihara cross-coupling polycondensation?
  Alvin Tanudjaja,Shinsuke Inagi,Fusao Kitamura,Toshikazu Takata,Ikuyoshi Tomita Dalton Trans., 2021,50, 3037-3043
• 4. An aptamer-based keypad lock system?
  Yaqing Liu,Jiangtao Ren,Jing Li,Jiyang Liu,Erkang Wang Chem. Commun., 2012,48, 802-804
• 5. Alternative synthesis of the anti-baldness compound RU58841?
  RSC Adv., 2014,4, 14143-14148

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Pyridinecarboxylic acids
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Pyridinecarboxylic acids and derivatives Pyridinecarboxylic acids

1-Methyl-1H-imidazo[4,5-c]pyridine-6-carboxylic acid (CAS 1234014-36-8): A Versatile Building Block in Medicinal Chemistry

The 1-Methyl-1H-imidazo[4,5-c]pyridine-6-carboxylic acid (CAS 1234014-36-8) represents an important heterocyclic compound that has gained significant attention in pharmaceutical research and drug discovery. This imidazo[4,5-c]pyridine derivative serves as a valuable scaffold for the development of various biologically active molecules, particularly in the field of kinase inhibitors and antiviral agents.

With the molecular formula C₈H₇N₃O₂, this nitrogen-rich heterocycle combines the structural features of both imidazole and pyridine rings, creating a unique pharmacophore that interacts effectively with biological targets. The presence of the carboxylic acid functional group at position 6 provides an excellent handle for further derivatization, making it a preferred intermediate in medicinal chemistry programs.

Recent trends in drug discovery have shown increased interest in imidazo[4,5-c]pyridine-based compounds, particularly as researchers explore novel treatments for viral infections and inflammatory conditions. The COVID-19 pandemic has accelerated research into small molecule antivirals, with many pharmaceutical companies screening libraries containing 1-Methyl-1H-imidazo[4,5-c]pyridine-6-carboxylic acid derivatives for potential therapeutic applications.

The synthesis of 1-Methyl-1H-imidazo[4,5-c]pyridine-6-carboxylic acid typically involves multi-step organic transformations starting from commercially available pyridine derivatives. Modern synthetic approaches often employ transition metal-catalyzed reactions to construct the imidazo[4,5-c]pyridine core, followed by selective methylation and oxidation steps to introduce the desired functional groups.

In pharmacological applications, this compound has shown promise as a building block for protein kinase inhibitors, particularly those targeting JAK and PI3K pathways. The rigid, planar structure of the imidazo[4,5-c]pyridine system allows for optimal interactions with the ATP-binding sites of various kinases, while the carboxylic acid group enables salt formation for improved solubility.

From a commercial perspective, CAS 1234014-36-8 has seen growing demand from contract research organizations and pharmaceutical companies engaged in early-stage drug discovery. Suppliers typically offer this compound with purity levels exceeding 98%, meeting the stringent requirements of medicinal chemistry applications. Current market analysis suggests steady growth in the imidazo[4,5-c]pyridine derivatives segment, driven by increased R&D investment in targeted therapies.

Researchers working with 1-Methyl-1H-imidazo[4,5-c]pyridine-6-carboxylic acid should note its stability under standard laboratory conditions. The compound is generally stable at room temperature when stored properly, though precautions should be taken to avoid prolonged exposure to moisture due to the presence of the carboxylic acid moiety. Analytical characterization typically includes HPLC, NMR, and mass spectrometry to confirm identity and purity.

Beyond pharmaceutical applications, this compound has found use in material science as a precursor for nitrogen-doped carbon materials. The thermal decomposition of imidazo[4,5-c]pyridine derivatives can yield materials with interesting electronic properties, potentially useful in energy storage applications.

For chemists considering the purchase of 1-Methyl-1H-imidazo[4,5-c]pyridine-6-carboxylic acid, it's important to verify the supplier's quality control processes and documentation. Many researchers seek answers to common questions such as: "What are the recommended storage conditions for this compound?" or "What synthetic routes are available for further functionalization?" These considerations reflect the practical challenges faced when working with specialized heterocycles.

Looking ahead, the future of imidazo[4,5-c]pyridine chemistry appears bright, with several drug candidates containing this scaffold currently in clinical trials. The versatility of 1-Methyl-1H-imidazo[4,5-c]pyridine-6-carboxylic acid as a synthetic intermediate ensures its continued relevance in both academic and industrial research settings.

In conclusion, CAS 1234014-36-8 represents an important tool in modern medicinal chemistry, offering researchers a versatile platform for drug discovery and development. Its unique structural features and multiple points for derivatization make it particularly valuable in the search for new therapeutic agents targeting various disease pathways.

• 1234014-41-5(1-ethyl-1H-Imidazo[4,5-c]pyridine-6-carboxylic acid)
• 1007387-32-7(4-methyl-1,4-dihydropyrrolo[3,2-b]pyrrole-2-carboxylate potassium salt)
• 1211590-38-3(3H-Imidazo[4,5-c]pyridine-6-carboxylic acid)
• 1234014-60-8(2-amino-1-methyl-1H-Imidazo[4,5-c]pyridine-6-carboxylic acid)
• 1007386-48-2(4-methyl-1H,4H-pyrrolo3,2-bpyrrole-2-carboxylic acid)
• 752213-01-7(9-methyl-9H-Pyrido[3,4-b]indole-3-carboxylic acid)
• 1234014-38-0(3-methyl-3H-imidazo4,5-cpyridine-6-carboxylic acid)
• 478149-14-3(1-methyl-1H-Pyrrolo[2,3-c]pyridine-5-carboxylic acid)
• 1234014-37-9(methyl 3-methyl-3H-imidazo4,5-cpyridine-6-carboxylate)
• 1078168-26-9(1-methyl-1H-Imidazo[4,5-c]pyridine-4-carboxylic acid)